Durham drug developer is a winner in war on terror.

PositionTriangle

Chimerix Inc. celebrated Valentine's Day by announcing it would receive $45 million of affection from venture capitalists, led by New Leaf Venture Partners. Two days later, the Durham-based drug developer won a $24.8 million government contract to develop a smallpox treatment that could be used against a bioterrorist attack. The one-year agreement with the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT